Biological characteristics, biosafety prevention and control strategies for the 2022 multi-country outbreak of monkeypox

IF 3.5 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Biosafety and Health Pub Date : 2022-12-01 DOI:10.1016/j.bsheal.2022.11.001

Chudan Liang , Jun Qian , Linna Liu

{"title":"Biological characteristics, biosafety prevention and control strategies for the 2022 multi-country outbreak of monkeypox","authors":"Chudan Liang , Jun Qian , Linna Liu","doi":"10.1016/j.bsheal.2022.11.001","DOIUrl":null,"url":null,"abstract":"<div>Monkeypox is a zoonotic disease caused by the monkeypox virus (MPXV), which is a potential biological warfare agent of bioterrorism and poses the greatest threat to the world’s public biosafety and health after variola virus (VARV). While the coronavirus disease 2019 (COVID-19) pandemic has not ended yet, monkeypox is spreading menacingly. The first case of monkeypox in a nonendemic country was confirmed on May 6th, 2022, while the first imported case from Asia was found on June 21st. There were more than 16 thousand reported cases as of July 23rd, the day the World Health Organization (WHO) declared the global monkeypox outbreak a public health emergency of international concern (PHEIC) at the same level as smallpox and COVID-19; while there were more than 53 thousand cases as of September 1st. Therefore, we will propose relevant biosafety prevention and control strategies after analyzing the etiology of the 2022 multi-country monkeypox outbreak from the biological feature, transmissibility, epidemic, and variability of MPXV.</div>","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643041/pdf/","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biosafety and Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590053622001574","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 5

Abstract

Monkeypox is a zoonotic disease caused by the monkeypox virus (MPXV), which is a potential biological warfare agent of bioterrorism and poses the greatest threat to the world’s public biosafety and health after variola virus (VARV). While the coronavirus disease 2019 (COVID-19) pandemic has not ended yet, monkeypox is spreading menacingly. The first case of monkeypox in a nonendemic country was confirmed on May 6^th, 2022, while the first imported case from Asia was found on June 21^st. There were more than 16 thousand reported cases as of July 23^rd, the day the World Health Organization (WHO) declared the global monkeypox outbreak a public health emergency of international concern (PHEIC) at the same level as smallpox and COVID-19; while there were more than 53 thousand cases as of September 1^st. Therefore, we will propose relevant biosafety prevention and control strategies after analyzing the etiology of the 2022 multi-country monkeypox outbreak from the biological feature, transmissibility, epidemic, and variability of MPXV.

查看原文本刊更多论文

2022年猴痘多国暴发的生物学特征及生物安全防控策略

猴痘是由猴痘病毒(MPXV)引起的人畜共患疾病，是一种潜在的生物恐怖主义生物战剂，是继天花病毒(VARV)之后对世界公共生物安全和健康构成最大威胁的病毒。虽然2019冠状病毒病(COVID-19)大流行尚未结束，但猴痘正在威胁性地传播。非流行国家的首例猴痘病例于2022年5月6日得到确认，而从亚洲输入的首例猴痘病例于6月21日被发现。截至7月23日，即世界卫生组织宣布全球猴痘疫情与天花和COVID-19同级为国际关注的突发公共卫生事件(PHEIC)的当天，已报告病例超过1.6万例;而截至9月1日，已有5.3万多例病例。因此，我们将从MPXV的生物学特征、传播性、流行性和变异性等方面分析2022年猴痘多国暴发的病因，提出相关的生物安全防控策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Biosafety and Health Medicine-Infectious Diseases

CiteScore

7.60

自引率

0.00%

发文量

116

审稿时长

66 days